SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-19-000870
Filing Date
2019-01-15
Accepted
2019-01-15 16:10:32
Documents
3
Period of Report
2019-01-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K atos20190115_8k.htm 8-K 28096
2 EXHIBIT 4.1 FORM OF 2019 OPTION AWARD AGREEMENT ex_132964.htm EX-4.1 42253
3 EXHIBIT 4.2 2010 STOCK OPTION AND INCENTIVE AGREEMENT, AS AMENDED JAN 13, 2019 ex_132965.htm EX-4.2 107440
  Complete submission text file 0001437749-19-000870.txt   178967
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA GENETICS INC (Filer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35610 | Film No.: 19527229
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1